- 2014. Vitamin D is not linked to folate status and mRNA expression of intestinal proton-coupled folate transporter. European Journal of Nutrition. 53: 1115-1122. doi: 10.1007/s00394-013-0614-7
- 2014. Plasma fibroblast growth factor 23, parathyroid hormone, 25-hydroxyvitamin D3, and risk of heart failure: A prospective, case-cohort study. Journal of Clinical Endocrinology and Metabolism. 99: 947-955. doi: 10.1210/jc.2013-2963
- 2013. Vitamin D: do we get enough? : A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporosis International. 24: 1567-1577. doi: 10.1007/s00198-012-2231-3
- 2013. Plasma 25-hydroxyvitamin D and its genetic determinants in relation to incident type 2 diabetes: a prospective case-cohort study. European Journal of Epidemiology. 28: 743-752. doi: 10.1007/s10654-013-9844-5
- 2013. DETERMINANTS OF VITAMIN D STATUS IN PATIENTS WITH STABLE ANGINA. Annals of Nutrition and Metabolism. 63: 241-241.
- 2013. Validation of the German Diabetes Risk Score within a population-based representative cohort. Diabetic Medicine. 30: 1047-1053. doi: 10.1111/dme.12216
- 2013. 25-HYDROXYVITAMIN D, ITS GENETIC DETERMINANTS AND THE RISK OF CARDIOVASCULAR DISEASES IN THE GERMAN ARM OF THE EPIC-STUDY. Annals of Nutrition and Metabolism. 63: 1128-1129.
- 2013. Plasma 25-hydroxyvitamin D and its genetic determinants in relation to incident myocardial infarction and stroke in the European Prospective Investigation into cancer and nutrition (EPIC)-Germany study. PLoS ONE. 8. 12 pages. doi: 10.1371/journal.pone.0069080
- 2013. BIOAVAILABILITY OF VITAMIN D2 AND D3 IN HEALTHY VOLUNTEERS - A RANDOMIZED TRIAL. Annals of Nutrition and Metabolism. 63: 909-909.
- 2013. Bioavailability of vitamin D-2 and D-3 in healthy volunteers, a randomized placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism. 98: 4339-4345. doi: 10.1210/jc.2012-4287
- 2012. Omega-3 status and the relationship between plasma asymmetric dimethylarginine and risk of myocardial infarction in patients with suspected coronary artery disease. Cardiology Research and Practice. 11 pages. doi: 10.1155/2012/201742
- 2012. Reliability of plasma fibroblast growth factor 23 as risk biomarker in epidemiological studies measured over a four-month period. Annals of Clinical Biochemistry. 49: 542-545. doi: 10.1258/acb.2012.011273
- 2011. Comparison of two nutritional interventions in obese families. Ernährungs-Umschau (1977). 58: 122-127.
- 2011. Vitamin D status in healthy volunteers during autumn and winter. Annals of Nutrition and Metabolism. 58: 36-36.
- 2011. Different classification of overweight and obesity in children and adolescents: effect on the frequency of overweight and obesity in Delitzsch, Germany. Annals of Nutrition and Metabolism. 58: 339-339.
- 2010. Plasma gamma-glutamyltransferase, cysteinyl-glycine, and oxidized low-density lipoprotein: a pathway associated with myocardial infarction risk? Arteriosclerosis, Thrombosis and Vascular Biology. 30: 2053-2058. doi: 10.1161/ATVBAHA.110.209346
- 2013. B vitamins and disease. Chapter 2, pages 21-34. In:
- 2013. B Vitamins and Folate : Chemistry, Analysis, Function and Effects. Royal Society of Chemistry. 855 pages. ISBN: 978-1-84973-369-4.
More information in national current research information system (CRIStin)
Selected Publications
2010
Heinz J, Kropf S, Domröse U, Westphal S, Borucki K, Luley C, Neumann KH, Dierkes J. B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial. Circulation. 2010 Mar 30;121(12):1432-8.
2009
Borucki K, Weikert C, Fisher E, Jakubiczka S, Luley C, Westphal S, Dierkes J. Haplotypes in the UGT1A1 gene and their role as genetic determinants of bilirubin concentration in healthy German volunteers. Clin Biochem. 2009 Nov;42(16-17):1635-41.
Heinz J, Kropf S, Luley C, Dierkes J. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis. Am J
Kidney Dis. 2009 Sep;54(3):478-89.
2008
Weikert C, Westphal S, Berger K, Dierkes J, Möhlig M, Spranger J, Rimm EB,
Willich SN, Boeing H, Pischon T. Plasma resistin levels and risk of myocardial
infarction and ischemic stroke. J Clin Endocrinol Metab. 2008 Jul;93(7):2647-53.
2007
Weikert C, Dierkes J, Hoffmann K, Berger K, Drogan D, Klipstein-Grobusch K,
Spranger J, Möhlig M, Luley C, Boeing H. B vitamin plasma levels and the risk of
ischemic stroke and transient ischemic attack in a German cohort. Stroke. 2007
Nov;38(11):2912-8
Dierkes J, Weikert C, Klipstein-Grobusch K, Westphal S, Luley C, Möhlig M,
Spranger J, Boeing H. Plasma pyridoxal-5-phosphate and future risk of myocardial
infarction in the European Prospective Investigation into Cancer and Nutrition
Potsdam cohort. Am J Clin Nutr. 2007 Jul;86(1):214-20.